BOXED O
WARNING O
: O
WARNING O
: O
HEMORRHAGE O
, O
GASTROINTESTINAL O
PERFORATION O
, O
COMPROMISED O
WOUND O
HEALING O
WARNING O
: O
HEMORRHAGE O
, O
GASTROINTESTINAL O
PERFORATION O
, O
COMPROMISED O
WOUND O
HEALING O
Hemorrhage B-NonOSE_AE
: O
Severe O
and O
sometimes O
fatal B-NonOSE_AE
hemorrhage B-OSE_Labeled_AE
, O
including O
gastrointestinal B-OSE_Labeled_AE
( O
GI O
) O
hemorrhage I-OSE_Labeled_AE
, O
has O
been O
reported O
in O
the O
patients O
who O
have O
received O
ZALTRAP O
in O
combination O
with O
FOLFIRI O
. O

Monitor O
patients O
for O
signs O
and O
symptoms O
of O
GI B-NonOSE_AE
bleeding I-NonOSE_AE
and O
other O
severe O
bleeding B-NonOSE_AE
. O

Do O
not O
administer O
ZALTRAP O
to O
patients O
with O
severe O
hemorrhage B-Not_AE_Candidate
[ O
see O
Dosage O
and O
Administration O
( O
2.2 O
) O
, O
Warnings O
and O
Precautions O
( O
5.1 O
) O
] O
. O

Gastrointestinal B-NonOSE_AE
Perforation I-NonOSE_AE
: O
Gastrointestinal B-OSE_Labeled_AE
( I-OSE_Labeled_AE
GI I-OSE_Labeled_AE
) I-OSE_Labeled_AE
perforation I-OSE_Labeled_AE
including O
fatal B-NonOSE_AE
GI B-OSE_Labeled_AE
perforation I-OSE_Labeled_AE
can O
occur O
in O
patients O
receiving O
ZALTRAP O
. O

Discontinue O
ZALTRAP O
therapy O
in O
patients O
who O
experience O
GI B-NonOSE_AE
perforation I-NonOSE_AE
[ O
see O
Dosage O
and O
Administration O
( O
2.2 O
) O
, O
Warnings O
and O
Precautions O
( O
5.2 O
) O
] O
. O

Compromised B-NonOSE_AE
Wound I-NonOSE_AE
Healing I-NonOSE_AE
: O
Severe O
compromised B-OSE_Labeled_AE
wound I-OSE_Labeled_AE
healing I-OSE_Labeled_AE
can O
occur O
in O
patients O
receiving O
ZALTRAP/FOLFIRI O
. O

Discontinue O
ZALTRAP O
in O
patients O
with O
compromised B-NonOSE_AE
wound I-NonOSE_AE
healing I-NonOSE_AE
. O

Suspend O
ZALTRAP O
for O
at O
least O
4 O
weeks O
prior O
to O
elective O
surgery O
, O
and O
do O
not O
resume O
ZALTRAP O
for O
at O
least O
4 O
weeks O
following O
major O
surgery O
and O
until O
the O
surgical O
wound O
is O
fully O
healed O
[ O
see O
Dosage O
and O
Administration O
( O
2.2 O
) O
, O
Warnings O
and O
Precautions O
( O
5.3 O
) O
] O
. O

EXCERPT O
: O
WARNING O
: O
HEMORRHAGE O
, O
GASTROINTESTINAL O
PERFORATION O
, O
COMPROMISED O
WOUND O
HEALING O
See O
full O
prescribing O
information O
for O
complete O
boxed O
warning O
. O

* O
Hemorrhage O
: O
Severe O
and O
sometimes O
fatal O
hemorrhage O
, O
including O
gastrointestinal O
( O
GI O
) O
hemorrhage O
, O
has O
been O
reported O
in O
patients O
who O
have O
received O
ZALTRAP O
. O

Do O
not O
administer O
ZALTRAP O
to O
patients O
with O
severe O
hemorrhage O
. O

( O
5.1 O
) O
* O
Gastrointestinal O
Perforation O
: O
Discontinue O
ZALTRAP O
therapy O
in O
patients O
who O
experience O
GI O
perforation O
. O

( O
5.2 O
) O
* O
Compromised O
Wound O
Healing O
: O
Discontinue O
ZALTRAP O
in O
patients O
with O
compromised O
wound O
healing O
. O

Suspend O
ZALTRAP O
for O
at O
least O
4 O
weeks O
prior O
to O
elective O
surgery O
, O
and O
do O
not O
resume O
for O
at O
least O
4 O
weeks O
following O
major O
surgery O
and O
until O
the O
surgical O
wound O
is O
fully O
healed O
. O

( O
5.3 O
) O

